Novavax to present at 2026 Jefferies Global Healthcare Conference on June 4

Novavax, a vaccine technology company, announced it will participate in the 2026 Jefferies Global Healthcare Conference with a fireside chat scheduled for June 4 in New York. The event will highlight Novavax's vaccine innovations and strategic growth plans, including partnerships and R&D efforts. A webcast of the session will be available on Novavax's investor website for 30 days, providing investors insight into the company's future direction and market strategy.